A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)
Clinical trial NCT00401596 · COMPLETED
Trial details
- NCT number
- NCT00401596
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-07-01
- Enrollment
- 1899
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.